Renin-angiotensin System Gene Polymorphisms and Endometrial Cancer

Overview

Journal Endocr Connect

Specialty Endocrinology

Date 2016 Apr 13

PMID 27068935

Citations 16

Authors

Kirsty G Pringle

Sarah J Delforce

Yu Wang

Katie A Ashton

Anthony Proietto

Geoffrey Otton

C Caroline Blackwell

Rodney J Scott

Eugenie R Lumbers

Affiliations

Soon will be listed here.

Abstract

Endometrial cancer (EC) is the most common gynaecological malignancy and its incidence is increasing. Dysregulation of the endometrial renin-angiotensin system (RAS) could predispose to EC; therefore, we studied the prevalence of RAS single nucleotide polymorphisms (SNPs) in Australian women with EC. SNPs assessed were AGT M235T (rs699); AGTR1 A1166C (rs5186); ACE A240T and T93C (rs4291, rs4292) and ATP6AP2 (rs2968915). They were identified using TaqMan SNP Genotyping Assays. The C allele of the AGTR1 SNP (rs5186) was more prevalent in women with EC (odds ratio (OR) 1.7, 95% confidence interval (CI) (1.2-2.3), P=0.002). The CC genotype of this SNP is associated with upregulation of the angiotensin II type 1 receptor (AGTR1). The G allele of AGT rs699, which is associated with higher angiotensinogen (AGT) levels, was less prevalent in women with EC (OR 0.54, 95% CI (0.39-0.74), P<0.001) compared with controls. AGT and AGT formed by removal of angiotensin I (des(Ang I)AGT) are both anti-angiogenic. In women with EC who had had hormone replacement therapy (HRT), the prevalence of the AGTR1 SNP (rs5186) and the ACE SNPs (rs4291 and rs4292) was greater than in women who had no record of HRT; SNP rs4291 is associated with increased plasma ACE activity. These data suggest there is an interaction between genotype, oestrogen replacement therapy and EC. In conclusion, the prevalence of two SNPs that enhance RAS activity was different in women with EC compared with healthy controls. These genetic factors may interact with obesity and hyperoestrogenism, predisposing ageing, obese women to EC.

Citing Articles

Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component.

de Melo I, Tavares V, Pereira D, Medeiros R Curr Issues Mol Biol. 2024; 46(5):4845-4873.

PMID: 38785560 PMC: 11120512. DOI: 10.3390/cimb46050292.

The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review.

Al-Kuraishy H, Al-Maiahy T, Al-Gareeb A, Alexiou A, Papadakis M, Saad H Cancer Rep (Hoboken). 2023; 7(1):e1920.

PMID: 38018319 PMC: 10809206. DOI: 10.1002/cnr2.1920.

Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review.

Khan N, Elsori D, Rashid G, Tamanna S, Chakraborty A, Farooqi A Front Oncol. 2023; 13:1235418.

PMID: 37869088 PMC: 10585148. DOI: 10.3389/fonc.2023.1235418.

Angiotensinogen, a promising gene signature for rectum and stomach adenocarcinoma patients.

Hu W, Abdel-Maksoud M, Khalid S, Malik A, Alkholief M, Mubarak A Am J Transl Res. 2023; 14(12):8879-8892.

PMID: 36628228 PMC: 9827296.

Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system.

Liu Y, Hao H, Lan T, Jia R, Cao M, Zhou L Front Endocrinol (Lausanne). 2023; 13:1080285.

PMID: 36619582 PMC: 9817105. DOI: 10.3389/fendo.2022.1080285.

References

Lumbers E, Wang Y, Delforce S, de Meaultsart C, Logan P, Mitchell M . Decidualisation of human endometrial stromal cells is associated with increased expression and secretion of prorenin. Reprod Biol Endocrinol. 2015; 13:129. PMC: 4658797. DOI: 10.1186/s12958-015-0127-8. View

Nelson L, Bulun S . Estrogen production and action. J Am Acad Dermatol. 2001; 45(3 Suppl):S116-24. DOI: 10.1067/mjd.2001.117432. View

Li X, Ahmed A . Compartmentalization and cyclic variation of immunoreactivity of renin and angiotensin converting enzyme in human endometrium throughout the menstrual cycle. Hum Reprod. 1998; 12(12):2804-9. DOI: 10.1093/humrep/12.12.2804. View

Chandra S, Narang R, Sreenivas V, Bhatia J, Saluja D, Srivastava K . Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study. PLoS One. 2014; 9(7):e101502. PMC: 4081645. DOI: 10.1371/journal.pone.0101502. View

Piastowska-Ciesielska A, Pluciennik E, Wojcik-Krowiranda K, Bienkiewicz A, Bednarek A, Ochedalski T . Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics. Tumour Biol. 2011; 33(3):767-74. DOI: 10.1007/s13277-011-0292-0. View

Strong A, Ohlstein J, Biagas B, Rhodes L, Pei D, Tucker H . Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 2015; 17:112. PMC: 4541745. DOI: 10.1186/s13058-015-0622-z. View

Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E . Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab. 2002; 46(3-4):147-51. DOI: 10.1159/000063081. View

Herr D, Bekes I, Wulff C . Local Renin-Angiotensin system in the reproductive system. Front Endocrinol (Lausanne). 2013; 4:150. PMC: 3798827. DOI: 10.3389/fendo.2013.00150. View

Koyama N, Nishida Y, Ishii T, Yoshida T, Furukawa Y, Narahara H . Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells. PLoS One. 2014; 9(3):e93050. PMC: 3965508. DOI: 10.1371/journal.pone.0093050. View

10.

Spurdle A, Thompson D, Ahmed S, Ferguson K, Healey C, OMara T . Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet. 2011; 43(5):451-4. PMC: 3770523. DOI: 10.1038/ng.812. View

11.

Gaunt T, Rodriguez S, Day I . Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics. 2007; 8:428. PMC: 2180187. DOI: 10.1186/1471-2105-8-428. View

12.

Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P . Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens. 2010; 24(2):241-6. DOI: 10.1038/ajh.2010.211. View

13.

Prescott J, Setiawan V, Wentzensen N, Schumacher F, Yu H, Delahanty R . Body Mass Index Genetic Risk Score and Endometrial Cancer Risk. PLoS One. 2015; 10(11):e0143256. PMC: 4659592. DOI: 10.1371/journal.pone.0143256. View

14.

Manjunathan R, Ragunathan M . In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane. Biol Res. 2015; 48:29. PMC: 4470073. DOI: 10.1186/s40659-015-0021-z. View

15.

Crosbie E, Zwahlen M, Kitchener H, Egger M, Renehan A . Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19(12):3119-30. DOI: 10.1158/1055-9965.EPI-10-0832. View

16.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

17.

Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams C, Charru A . Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992; 71(1):169-80. DOI: 10.1016/0092-8674(92)90275-h. View

18.

Scott R, McPhillips M, Meldrum C, Fitzgerald P, Adams K, Spigelman A . Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet. 2000; 68(1):118-127. PMC: 1234904. DOI: 10.1086/316942. View

19.

Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I . Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol. 2006; 136(1):74-7. DOI: 10.1016/j.ejogrb.2006.08.012. View

20.

Deckers I, van den Brandt P, van Engeland M, van Schooten F, Godschalk R, Keszei A . Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid. Int J Cancer. 2014; 136(5):1104-16. DOI: 10.1002/ijc.29060. View